TheraRadar
← Back
Data updated: Mar 29, 2026

PIRAMAL

CardiovascularNeurology
Generics

PIRAMAL is a generic drug manufacturer focused on Cardiovascular, Neurology.

2018
Since
7
Drugs
-
Trials
76
Approved (2yr)

Key Drugs

OLMESARTAN MEDOXOMIL, AMLODIPINE AND HYDROCHLOROTHIAZIDE
amlodipine besylate
Cardiovascular
AT1 receptor 3 indications · 2016

Top Drug Revenues Pro

Loading...

Revenue Over Time Pro

Loading...

Recent Activity

VARENICLINE TARTRATE 2026-01-09
VARENICLINE TARTRATE 2025-12-18
Labeling
OLMESARTAN MEDOXOMIL, AMLODIPINE AND HYDROCHLOROTHIAZIDE 2025-11-24
CISATRACURIUM BESYLATE 2025-11-03
Labeling
VARENICLINE TARTRATE 2025-10-29
DEFERASIROX 2025-10-21
Labeling
DEFERASIROX 2025-10-21
Labeling
DEFERASIROX 2025-10-21
Labeling
SEC Filings Pro
Loading...

Therapeutic Areas

Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5

Cardiovascular 92%
2 drugs
Neurology 8%
0 drugs Phase 1: 1

Pipeline Forecast

Loading...

Upcoming Trial Milestones Pro

Loading...

Patent Cliff Pro

Loading...

Competitors by Therapeutic Area

GE HEALTHCARE specialty
Neurology, Cardiovascular
Novo Nordisk big-pharma
Cardiovascular, Neurology
LEDERLE big-pharma
Cardiovascular, Neurology
PAI HOLDINGS PHARM big-pharma
Neurology, Cardiovascular
VALIDUS PHARMS specialty
Cardiovascular, Neurology